Review of the Use of Animal Models of Human Polycystic Kidney Disease for the Evaluation of Experimental Therapeutic Modalities

被引:8
|
作者
Nagao, Shizuko [1 ]
Yamaguchi, Tamio [1 ,2 ]
机构
[1] Fujita Hlth Univ, Adv Res Ctr Anim Models Human Dis, Toyoake 4701192, Japan
[2] Suzuka Univ Med Sci, Fac Hlth Sci, Dept Med Technol, Suzuka 5100293, Japan
关键词
cystic kidney; animal model; spontaneous; mutation; gene targeting; MOUSE MODELS; CYST GROWTH; PROGRESSION; EXPRESSION; TOLVAPTAN; RAT;
D O I
10.3390/jcm12020668
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant polycystic kidney disease, autosomal recessive polycystic kidney disease, and nephronophthisis are hereditary disorders with the occurrence of numerous cysts in both kidneys, often causing chronic and end-stage renal failure. Animal models have played an important role in recent advances in research not only on disease onset and progressive mechanisms but also on the development of therapeutic interventions. For a long time, spontaneous animal models have been used as the primary focus for human diseases; however, after the identification of the nucleotide sequence of the responsible genes, PKD1, PKD2, PKHD1, and NPHPs, various types of genetically modified models were developed by genetic and reproductive engineering techniques and played the leading role in the research field. In this review, we present murine models of hereditary renal cystic diseases, discussing their potential benefits in the development of therapeutic strategies.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Animal Models for Human Polycystic Kidney Disease
    Nagao, Shizuko
    Kugita, Masanori
    Yoshihara, Daisuke
    Yamaguchi, Tamio
    EXPERIMENTAL ANIMALS, 2012, 61 (05) : 477 - 488
  • [2] Experimental Models of Polycystic Kidney Disease: Applications and Therapeutic Testing
    Sieben, Cynthia J.
    Harris, Peter C.
    KIDNEY360, 2023, 4 (08): : 1155 - 1173
  • [3] Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities
    Torres, V. E.
    Harris, P. C.
    JOURNAL OF INTERNAL MEDICINE, 2007, 261 (01) : 17 - 31
  • [4] Advances in therapy for polycystic kidney disease: From animal models to human disease
    Torres, VE
    FASEB JOURNAL, 2004, 18 (05): : A778 - A778
  • [5] Evaluating the biological complexity of animal models of human disease and emerging therapeutic modalities
    Dorner, Andrew J.
    Schaub, Robert
    CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (05) : 531 - 533
  • [6] ANIMAL-MODELS OF POLYCYSTIC KIDNEY-DISEASE
    AZIZ, N
    BIOESSAYS, 1995, 17 (08) : 703 - 712
  • [7] Murine models of polycystic kidney disease: molecular and therapeutic insights
    Guay-Woodford, LM
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 285 (06) : F1034 - F1049
  • [8] Effects of amiloride in two animal models of polycystic kidney disease (PKD).
    Wang, XF
    Li, M
    Qian, Q
    Harris, PC
    Torres, VE
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 509A - 509A
  • [9] Therapeutic microRNAs in polycystic kidney disease
    Yheskel, Matanel
    Patel, Vishal
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2017, 26 (04): : 282 - 289
  • [10] Polycystic kidney disease and therapeutic approaches
    Park, Eun Young
    Woo, Yu Mi
    Park, Jong Hoon
    BMB REPORTS, 2011, 44 (06) : 359 - 368